Considering that 5-FU-based regimens are the first line chemotherapy treatments against GC and 5-FU is associated with ER stress and autophagy [27, 50], we explored the influence of SEC23A on 5-FU efficacy in GC cells. The gene discussed is SEC23A; the disease is gastric cancer.